Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...

There is an inverse bidirectional association between cancer and dementia, a relationship that holds across cancer and dementia subtypes.

BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand with ...

Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune ...

Cancer cells have recently been shown to collaborate to obtain vital nutrients from their environment, a phenomenon that was ...

Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say researchers from the University of Leeds and The Institute of Cancer Research.

NICE's initial guidance on Breyanzi concluded it was not a cost-effective option for patients, but the agency said this ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

Hundreds of people with aggressive blood cancer will be offered a groundbreaking one-off personalised therapy that ...

Hosts of many popular true crime podcasts will headline a murder-themed cruise next year that’s being billed as a first-of-its kind immersive mystery experience at sea. The cruise will feature ...